Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis
暂无分享,去创建一个
M. V. van Oijen | H. V. van Laarhoven | E. Ter Veer | A. Creemers | L. de Waal | T. van den Ende | E. ter Veer
暂无分享,去创建一个
M. V. van Oijen | H. V. van Laarhoven | E. Ter Veer | A. Creemers | L. de Waal | T. van den Ende | E. ter Veer